Robert W. Postma - Jun 22, 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Jun 22, 2022
Transactions value $
$0
Form type
4
Date filed
6/24/2022, 04:35 PM
Previous filing
Sep 3, 2021
Next filing
Dec 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +40K +3.33% $0.00 1.24M Jun 22, 2022 Direct F1
holding TCRT Common Stock 4.25M Jun 22, 2022 See Footnote F2
holding TCRT Common Stock 3.57K Jun 22, 2022 By Spouse's IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +100K $0.00 100K Jun 22, 2022 Common Stock 100K $0.82 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.
F2 The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
F3 The option vests in twelve equal monthly installments beginning on July 13, 2022.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney